Katarina Luptakova

Technik-/Wissenschafts-/F&E-Leiter bei XILIO THERAPEUTICS, INC.

Vermögen: - $ am 30.04.2024

Health Technology

Consumer Services

Aktive Positionen von Katarina Luptakova

Unternehmen	Position	Beginn	Ende
XILIO THERAPEUTICS, INC.	Technik-/Wissenschafts-/F&E-Leiter	01.10.2022	-

Unternehmen	Position	Beginn	Ende
TESARO INC	Technik-/Wissenschafts-/F&E-Leiter	-	-
CONSTELLATION PHARMACEUTICALS, INC.	Corporate Officer/Principal	-	-

University of Commenius

Doctorate Degree

International

Vereinigte Staaten	4
Slowakei	2

Operativ

Chief Tech/Sci/R&D Officer	2
Corporate Officer/Principal	1
Doctorate Degree	1

Sektoral

Health Technology	4
Consumer Services	2

Besetzte Positionen

Aktive

Inaktive

Börsennotierte Unternehmen

Private Unternehmen

Börsennotierte Unternehmen	1
XILIO THERAPEUTICS, INC.	Health Technology

Private Unternehmen	2
Constellation Pharmaceuticals, Inc. Constellation Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Constellation Pharmaceuticals, Inc. is a clinical-stage biopharmaceutical company, which engages in the development of novel therapeutics in the field of epigenetics. The firm utilizes epigenetics platform, which enables to validate targets and generate small molecules against these targets that selectively modulate gene expression in tumor and immune cells to drive anti-tumor activity. Its product include CPI-0610, CPI-1205, and CPI-0209. The company was founded by Danny Reinberg, David Allis, and Yang Shi on January 11, 2008 and is headquartered in Cambridge, MA.	Health Technology
Tesaro, Inc. Tesaro, Inc. Pharmaceuticals: MajorHealth Technology TESARO, Inc. is an oncology-focused biopharmaceutical company, which engages in the research and development of biopharmaceutical products. The firm offers Niraparib products. The company was founded by Leon Oliver Moulder, Jr., Mary Lynne Hedley, and Richard J. Rodgers on March 26, 2010 and is headquartered in Waltham, MA.	Health Technology

Private Unternehmen

Health Technology